Companies / United Kingdom
Ardana Launches Breakthrough Incontinence Drug
November 2006 | Product LaunchSwitzerland's Novartis and local firm Ardana have launched Emselex (darifenacin) in the UK for the treatment of overactive bladder (OAB). BMI expects the product to post strong sales given its improved side-effect profile compared to existing therapeutics.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.




